Biotechnology research and development laboratories or services · Texas

Smith + Nephew Inc. Austin South

Austin, TX · ~157 workers · 3 years of OSHA Injury Tracking Application data.

C
Average Safety Record
0.0
Avg TCR
0.5
Industry avg
0
Fatalities
Subscribe to safety-record updates (RSS)

The verdict

Smith + Nephew Inc. Austin South runs at 0% of its industry's injury rate - about level with the typical Biotechnology research and development laboratories or services workplace, earning a grade C.

Smith + Nephew Inc. Austin South: 0.0 TCR = 0% of Biotechnology research and development laboratories or services BLS 0.5 · 3y Form 300A (see methodology below)

Smith + Nephew Inc. Austin South safety composite

Smith + Nephew Inc. Austin South scores strongest on total case rate (tcr) (safer than 100% of same-industry peers) and weakest on fatalities (safer than 50%), blended into one 0-100 breakdown against same-industry peers. A missing measure drops out and redistributes its weight rather than deflating the score. This is a per-dimension breakdown, distinct from the single letter grade above it (which weights TCR alone against the BLS industry benchmark).

B

79/100

Percentile-weighted across 3 of 3 measures

Total Case Rate (TCR)
A 0 per 100 workers

Safer than 100% of industry peers

DART rate
B 0 per 100 workers

Safer than 76% of industry peers

Fatalities
D 0

Safer than 50% of industry peers

Benchmarked live against every credibly-rated employer in the same NAICS industry code in the current OSHA extract (a segment must have at least 8 rated peers to benchmark). Not a legal or compliance determination; PlainSafetyScore's own weighting (TCR 40%, DART 35%, fatalities 25%).

Smith + Nephew Inc. Austin South held a steady TCR band

Smith + Nephew Inc. Austin South's TCR held near 0.0 from 0.0 in 2021 to 0.0 in 2024. Peak filing year was 2021 at 0.0 TCR.

2021=0.0 · 2023=0.0 · 2024=0.0

OSHA ITA Form 300A scorecard

Establishment book 541711 · Austin, TX AT/BELOW-IND · MID

Grade C · TCR 0.0 · 0% of ind

  • DART 0.0 DART
  • RANK #0/4
  • PHOTO GSK/ViiV- Durham
  • BOOK 3y book
  • INJ 0 inj
  • SIZE ~157 FTE

Nearest TCR peer: GSK/ViiV- Durham (0.1 TCR gap)

Read with this employer → · Industry book → · Texas employers → · Look up another →

Smith + Nephew Inc. Austin South in the TCR neighbourhood

Average Total Case Rate among this establishment and nearest same-industry peers

TCR

What this shows Smith + Nephew Inc. Austin South averages 0.0 TCR (0% of the Biotechnology research and development laboratories or services BLS benchmark).

Source U.S. Department of Labor, OSHA Injury Tracking Application (Form 300A) As of 2026-08-25

Smith + Nephew Inc. Austin South TCR series: 2021=0 · 2023=0 · 2024=0 · BLS 0.5

Where Smith + Nephew Inc. Austin South falls in its industry

189 Biotechnology research and dev establishments

Safer than 100% of graded establishments in this industry, whose median TCR is 0.8.

More dangerous than peersSafer than peers

Narrower to Texas alone (the establishments it most directly competes with for workers and contracts): ranked #0 safest of 4 Biotechnology research and dev employers in Texas.

Smith + Nephew Inc. Austin South (157 employees, TCR 0.0) among 29 same-industry peers, split at the industry median of 296 employees and a TCR of 0.8 2×2 strategic matrix plotting 30 entities by Average employees (X) and Total Case Rate (Y), with a crosshair dividing the plot into four quadrants. Larger & higher-riskSmaller & higher-riskLarger & saferSmaller & safer than peers 01,0002,0003,0004,0005,000 05101520 Average employees Total Case Rate Smith + Nephew Inc. Austin South
Smith + Nephew Inc. Austin South (157 employees, TCR 0.0) among 29 same-industry peers, split at the industry median of 296 employees and a TCR of 0.8

Smith + Nephew Inc. Austin South has fewer employees than the Biotechnology research and development l median and a lower injury rate than the industry's median TCR of 0.8. Workforce size and injury rate do not always move together within the same industry -- some of its smaller peers run higher rates than its larger ones, and vice versa.

Year-by-Year Safety Data

Year TCR DART Injuries Illnesses Fatalities
2024 0.0 0.0 0 0 0
2023 0.0 0.0 0 0 0
2021 0.0 0.0 0 0 0

OSHA ITA peer cross-reference

Establishment peer ledger

541711 · TX · Austin

189 Biotechnology research and development laboratories or services employers nationwide with a credible TCR · 38,394 rated employers in Texas with headcount on file · 1,645 employers in Austin, TX · 4 cross-state NAT-TCR peers · 4 cross-state NAT-SIZE peers. Closest matches by relationship code are listed below.

Rel Establishment Metric
NAICS-TCR GSK/ViiV- Durham 0.1 TCR
NAICS-TCR Syngenta Crop Protection, LLC. 0.1 TCR
NAICS-TCR International Flavors and Fragrances 0.1 TCR
NAICS-TCR Thermo Fisher Scientific 0.1 TCR
STATE-SIZE Devon Energy Corporation - Bridgeport 157 FTE
STATE-SIZE CenterPoint Energy - Cypress 157 FTE
STATE-SIZE ODESSA TX WEST 157 FTE
STATE-SIZE OCC Civil and Mechanical 157 FTE
CITY-NEAR Ensign Services 11,325 FTE
CITY-NEAR NA-US-TX-Austin-Giga Texas 8,621 FTE
CITY-NEAR 6017-Loc: CORP LOC - US Austin 6,911 FTE
CITY-NEAR 6017-CORP LOC - USA UNITED STATES - AST 5,272 FTE
NAT-TCR US Foods, Inc. Rosemont 0.0 TCR
NAT-TCR Brookdale Conway 0.0 TCR
NAT-TCR Matt Bowers Nissan EasternShore 0.0 TCR
NAT-TCR Matt Bowers Ford Metairie 0.0 TCR
NAT-SIZE Syntec Optics 157 FTE
NAT-SIZE Noramco 157 FTE
NAT-SIZE PotlatchDeltic Manufacturing LLC, Ola 157 FTE
NAT-SIZE TRU 157 FTE

Rel codes: NAICS-TCR · STATE-SIZE · CITY-NEAR · NAT-TCR/NAT-SIZE cross-state. Read with this employer →

Data Source: OSHA Injury Tracking Application (ITA), mandatory establishment-level injury/illness reports. Grades compare employer Total Case Rate (TCR) to BLS IIF industry benchmarks. Data covers years reported by this establishment: 2024, 2023, 2021. This is publicly available government data - not a legal determination of workplace conditions.

Read our methodology - how this data is sourced, computed, and verified.

Data sourced from official public datasets. See our methodology for details.